Get the latest tech news
Aqemia raises $38M to find new drugs by meshing theoretical physics with GenAI
Aqemia, a French startup that's meshing "quantum-inspired physics" with machine learning to find new drugs, has raised $38M.
That includes a new office in London that’s set to open in early 2025 — a move designed to give Aqemia “access to the UK’s rich talent pool,” according to a press release. “Less than a year after our last round, this successful fundraising and the opening of our new London office mark significant strides toward our ambition to accelerate the discovery of new medicines on a global scale,” Levesque said in a statement. Aside from lead backer Cathay Innovation, Aqemia’s latest round saw participation from existing investors Wendel, Bpifrance Large Venture, Eurazeo, and Elaia.
Or read this on TechCrunch